- Source type
- Meta-analysis
- Access type
- Abstract/index
- Publisher
- Critical Reviews in Food Science and Nutrition
- Indexed by
- PubMed
- Date
- 2017
- Added
- 2026-07-01
Trust profile
VV Source Trust Matrix v1.0
VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.
91
Government health research
- Publisher type
- Government research
- Bias profile
- Low
This source is strongest for safety and clinical outcomes and weaker for consumer context and regulatory status.
VV Source Fit Score 1.0
Fit by use case
Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.
- Regulatory status
- 66/100
- Context Source
- Clinical outcomes
- 90/100
- Primary Anchor
- Mechanism
- 90/100
- Primary Anchor
- Safety
- 92/100
- Primary Anchor
- Consumer context
- 88/100
- Strong Support
- Trial discovery
- 89/100
- Strong Support
Best used for
- Research synthesis
- Public-health context
- Safety resources
Weak for
- Primary endpoint extraction when a study is available
Used in Viral Vitalism
Vegan Diets Can Be Elite or Deficient
Roles: Supporting evidence
Show section-level references
Vegetarian, vegan diets and multiple health outcomes: a systematic review with meta-analysis of observational studies
Roles: Supporting evidence
Show section-level references
Related studies
Related sources
CIRM: clinical and preclinical development awards
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 91
- Publisher
- CIRM
- Access
- Official
- Usage
- 1 connection
ClinicalTrials.gov: trial registry search for FourLight-3 context
Canonical source record for the republished rapid brief jamie-lynne-tarailo-breast-cancer-trial-close-to-home.
- Trust score
- 91
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 0 connections
FDA: approves sacituzumab govitecan-hziy for first-line TNBC indications
Canonical source record for the republished rapid brief fda-trodelvy-first-line-triple-negative-breast-cancer.
- Trust score
- 94
- Publisher
- FDA
- Access
- Official
- Usage
- 1 connection
FDA: oncology approval notifications
Canonical source record for the republished rapid brief fda-trodelvy-first-line-triple-negative-breast-cancer.
- Trust score
- 94
- Publisher
- FDA
- Access
- Official
- Usage
- 1 connection
FDA: Tregzi approval press announcement
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 94
- Publisher
- FDA
- Access
- Official
- Usage
- 1 connection
Nature Medicine: biological aging and generational shifts in early-onset cancer
Canonical source record for the republished rapid brief accelerated-biological-aging-early-onset-cancer-risk.
- Trust score
- 91
- Publisher
- Nature Medicine
- Access
- Publisher
- Usage
- 1 connection
